Cutaneous T-cell lymphoma risk by dupilumab indication: A multicenter cohort study using TriNetX

Published: 11 May 2026| Version 1 | DOI: 10.17632/8dr6txjpjn.1
Contributor:
Jaanvi Mehta

Description

Supplementary Information

Files

Categories

Dermatology, Cutaneous T-Cell Lymphoma

Licence